ABMS

Al-Bilad Medical ServicesASE:ABMS Stock Report

Market Cap

د.أ24.3m

7D

0%

1Y

42.1%

Updated

17 Sep, 2021

Data

Company Financials
ABMS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends0/6

ABMS Overview

Al-Bilad Medical Services Co. operates a general hospital to provide health, preventive, diagnostic, and therapeutic services in Jordan.

Price History & Performance

Summary of all time highs, changes and price drops for Al-Bilad Medical Services
Historical stock prices
Current Share Priceد.أ0.81
52 Week Highد.أ0.55
52 Week Lowد.أ0.81
Beta0.27
1 Month Change3.85%
3 Month Change15.71%
1 Year Change42.11%
3 Year Change-10.00%
5 Year Change-14.74%
Change since IPO-29.95%

Recent News & Updates

Shareholder Returns

ABMSJO HealthcareJO Market
7D0%-0.8%-0.4%
1Y42.1%4.9%36.5%

Return vs Industry: ABMS exceeded the JO Healthcare industry which returned 4.9% over the past year.

Return vs Market: ABMS exceeded the JO Market which returned 36.5% over the past year.

Price Volatility

Is ABMS's price volatile compared to industry and market?
ABMS volatility
ABMS Beta0.27
Industry Beta0.61
Market Beta1

Stable Share Price: Insufficient data to determine ABMS's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine ABMS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996607Ahmad Mohammed Al-Ahmadhttps://istiklal.jo

Al-Bilad Medical Services Co. operates a general hospital to provide health, preventive, diagnostic, and therapeutic services in Jordan. The company also provides financial brokerage services. Al-Bilad Medical Services Co. was founded in 1996 and is based in Amman, Jordan.

Al-Bilad Medical Services Fundamentals Summary

How do Al-Bilad Medical Services's earnings and revenue compare to its market cap?
ABMS fundamental statistics
Market Capد.أ24.30m
Earnings (TTM)د.أ528.09k
Revenue (TTM)د.أ13.51m

46.0x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ABMS income statement (TTM)
Revenueد.أ13.51m
Cost of Revenueد.أ9.64m
Gross Profitد.أ3.87m
Expensesد.أ3.34m
Earningsد.أ528.09k

Last Reported Earnings

Dec 31, 2020

Next Earnings Date

n/a

Earnings per share (EPS)0.018
Gross Margin28.64%
Net Profit Margin3.91%
Debt/Equity Ratio3.9%

How did ABMS perform over the long term?

See historical performance and comparison

Valuation

Is Al-Bilad Medical Services undervalued compared to its fair value and its price relative to the market?

46.02x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ABMS's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate ABMS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: ABMS is poor value based on its PE Ratio (46x) compared to the Asian Healthcare industry average (24.7x).

PE vs Market: ABMS is poor value based on its PE Ratio (46x) compared to the JO market (13.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ABMS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ABMS is good value based on its PB Ratio (0.9x) compared to the XA Healthcare industry average (2.3x).


Future Growth

How is Al-Bilad Medical Services forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Al-Bilad Medical Services has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Al-Bilad Medical Services performed over the past 5 years?

5.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ABMS has high quality earnings.

Growing Profit Margin: ABMS's current net profit margins (3.9%) are higher than last year (0.8%).


Past Earnings Growth Analysis

Earnings Trend: ABMS has become profitable over the past 5 years, growing earnings by 5.7% per year.

Accelerating Growth: ABMS's earnings growth over the past year (399.6%) exceeds its 5-year average (5.7% per year).

Earnings vs Industry: ABMS earnings growth over the past year (399.6%) exceeded the Healthcare industry 34.1%.


Return on Equity

High ROE: ABMS's Return on Equity (2%) is considered low.


Financial Health

How is Al-Bilad Medical Services's financial position?


Financial Position Analysis

Short Term Liabilities: ABMS's short term assets (JOD12.5M) exceed its short term liabilities (JOD1.7M).

Long Term Liabilities: ABMS's short term assets (JOD12.5M) exceed its long term liabilities (JOD7.4M).


Debt to Equity History and Analysis

Debt Level: ABMS's debt to equity ratio (3.9%) is considered satisfactory.

Reducing Debt: ABMS's debt to equity ratio has reduced from 12.9% to 3.9% over the past 5 years.

Debt Coverage: ABMS's debt is well covered by operating cash flow (90.8%).

Interest Coverage: ABMS's interest payments on its debt are not well covered by EBIT (2.4x coverage).


Balance Sheet


Dividend

What is Al-Bilad Medical Services's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ABMS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ABMS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ABMS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ABMS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ABMS is not paying a notable dividend for the JO market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ABMS's dividend in 3 years as they are not forecast to pay a notable one for the JO market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

د.أ677

CEO Compensation


CEO

Ahmad Mohammed Al-Ahmad (37 yo)

no data

Tenure

د.أ677

Compensation

Mr. Ahmad Mohammed Mahmoud Al-Ahmad serves as General Manager at Al-Bilad Medical Services Co. and served as its Internal Audit Manager since January 26, 2015. Mr. Al-Ahmad has been a Representative Direct...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Ahmad Mohammed's total compensation is reasonable compared to companies of similar size in the JO market.

Compensation vs Earnings: Insufficient data to compare Ahmad Mohammed's compensation with company performance.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Al-Bilad Medical Services Co.'s employee growth, exchange listings and data sources


Key Information

  • Name: Al-Bilad Medical Services Co.
  • Ticker: ABMS
  • Exchange: ASE
  • Founded: 1996
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: د.أ24.300m
  • Shares outstanding: 30.00m
  • Website: https://istiklal.jo

Number of Employees


Location

  • Al-Bilad Medical Services Co.
  • PO Box 1493
  • Amman
  • 11821
  • Jordan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/17 11:31
End of Day Share Price2021/09/16 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.